1. Average EBITDA in all ASCs was $2,011,000.
2. Median EBITDA in all ASCs was $1,481,000.
Average EBITDA based on number of ORs
3. ASCs with 1-2 ORs — $958,000
4. ASCs with 3-4 ORs — $1,388,000
5. ASCs with more than 4 ORs — $1,960,000
Average EBITDA based on case volume
6. ASCs with fewer than 3,000 cases per year — $454,000
7. ASCs with 3,000-5,999 cases per year — $1,238,000
8. ASCs with more than 5,999 cases per year — $1,967,000
Average EBITDA based on net revenue
9. ASCs with less than $4,500,000 in net revenue — $493,000
10. ASCs with $4,500,000-$6,999,999 in net revenue — $1,270,000
11. ASCs with more than $6,999,999 in net revenue — $2,858,000
VMG information comes from VMG Health’s Multi-Specialty ASC Intellimarker 2010 benchmarking study. VMG Health is a leading valuation and transaction advisory firm in healthcare. To receive a complimentary copy of VMG Health’s 2010 Multi-Specialty ASC Intellimarker, click here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.